Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2004, p. 2127-2133, Vol. 42, No. 5
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.5.2127-2133.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, La Trobe University, Victoria 3086,1 Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria 3010,2 Department of Paediatrics,3 Pathology Laboratory, Alice Springs Hospital, Alice Springs, Northern Territory 0870, Australia4
Received 18 August 2003/ Returned for modification 4 October 2003/ Accepted 21 January 2004
|
|
|---|
|
|
|---|
In relation to this, identification of group C rotaviruses would have been hindered since commercially used enzyme immunoassays (EIAs) would generally not recognize the group C rotavirus-specific antigen on the inner capsid protein VP6, which carries the group-specific antigen of a rotavirus group. Polyacrylamide gel electrophoresis (PAGE), which can be used to distinguish between different serogroups of rotavirus (17), and electron microscopy are not often used to detect rotavirus in stool specimens (9). Confirmatory tests, such as with reverse transcription-PCR (RT-PCR) with group C rotavirus-specific primers (5, 8) and EIAs with group C rotavirus-specific reagents have not been widely used, usually only in reference laboratories (9).
The structure of group C rotaviruses is similar to that of group A rotaviruses with virus particles characterized by double capsids enclosing a genome of 11 double-stranded RNA segments (17). The genome segments, however, form basic groupings on polyacrylamide gels different from those of group A and the other serogroups of rotaviruses (17). The coding assignments of group C rotavirus genes also appear to differ from those of group A rotaviruses for several major structural proteins, including VP4, VP6, and VP7 (9).
A high degree of variability in the sequence of the gene coding for VP7, the major outer capsid protein of rotaviruses, is evident among group A rotaviruses, both among and between human and animal strains. Sequence variation is also evident between VP7 genes of human and animal group C rotaviruses, but among human group C rotavirus isolates themselves from many different parts of the world remarkable sequence conservation has been noted in this gene (1, 3, 6, 9, 11). A high degree of conservation has also been evident between the sequences of the VP4 genes of human group C rotavirus isolates from different parts of the world, but a greater difference was noted between these sequences and those of the VP4 genes of bovine and porcine group C rotavirus strains (1, 4).
Human group C rotaviruses have generally proved difficult to grow in cell culture, and this has hindered the use of neutralization assays to serotype them. Type-specific monoclonal antisera, such as those available for group A rotaviruses, are not available for human group C rotaviruses. Relatedness between human group C rotaviruses has therefore thus far only been inferred from sequence analysis of (essentially) the VP7 genes (9).
We report here on the incidence of human group C rotavirus over 16 years in central Australia and on the sequences of the VP7 genes of four and the sequences of the VP4 genes of two of the isolates identified during a 7-year span within this period.
|
|
|---|
Virus detection. Rotavirus was detected in clarified stool samples by electron microscopy, and then group C rotavirus was specifically identified by comparison of the virus genome profiles obtained on polyacrylamide gels with genome profiles of group C rotaviruses isolated elsewhere (17). Genome profiles were visualized by silver staining after PAGE of extracted viral RNA. For confirmation as group C rotaviruses, if sequencing of one or more genes of an isolate was not carried out, the PCR method of Gouvea et al. (5) was used.
Extraction of viral RNA for PCR and sequencing. Homogenized 10 to 20% stool suspensions in phosphate-buffered saline (pH 7.2) were clarified by centrifugation at 13,000 x g for 10 s, and the supernatant adjusted to 1% with respect to sodium dodecyl sulfate and 0.1 M with respect to sodium acetate buffer (pH 5.4). After this was mixed, an equal volume of 1:1 phenol-chloroform was added, the mixture vortex mixed for 30 s, and the phases were separated by centrifugation at 13,000 x g for 30 s. Rotavirus RNA was extracted from the aqueous phase by using a commercial glass powder preparation (RNAID kit; Bio 101, Vista, Calif.). After the glass powder matrix had been resuspended in the aqueous phase by vortexing, the mixture was rocked for several minutes before the matrix was pelleted, and the supernatant was removed. The matrix, with viral RNA attached, was then washed twice with the supplied wash buffer by resuspension in 500 µl of the buffer and then pelleted again. After the second wash the matrix-RNA was resuspended in 25 µl of sterile distilled water, and this mixture was held at 55°C for 10 min in a water bath. The matrix was then pelleted, and the supernatant containing the viral RNA was stored at 80°C until required.
RT-PCR. For RT and transcription of the full-length of the VP7 gene, the primers used comprised the common first 21 bases of this gene in the forward direction for group C rotaviruses and the common first 21 bases of the complementary strand in the reverse direction. For RT and transcription of the VP4 gene, the primers comprised the common first 20 bases of the gene in the forward direction and the common first 20 bases of the complementary strand in the reverse direction. For the reaction, after a denaturing step at 97°C for 5 min, followed immediately by chilling in an ice-salt bath, 5 µl of extracted RNA plus 3.5 µl of dimethyl sulfoxide was added to a 41-µl mixture containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 4 mM MgCl2, 1 mM concentrations (each) of dATP, dCTP, dGTP and dTTP, 500 ng of each primer, and 12.5 U of avian myeloblastosis virus reverse transcriptase (Roche). After RT at 42°C for 60 min, 2.5 U of Taq DNA polymerase was added, and amplification was carried out for 30 cycles of 94°C for 1 min, 42°C for 2 min, and 72°C for 2 min.
Nucleotide sequencing. Primers of 20 bases derived from the published sequences of the VP7 gene of the human group C rotavirus Bristol strain (6) and the VP4 gene from the same strain (4), sited at approximately 200-base intervals along both strands of the genes, were used in further PCR amplification of subsections of these genes for sequencing. The primers used for RT or amplification were also utilized for this. The reaction mixture and PCR cycling conditions used were as outlined above except that 2 mM MgCl2 and 200 ng of each of the primers was used. The PCR products were then excised after having been electrophoresed on 1.8% agarose gels and further purified by using the Qiaex II DNA purification kit (Qiagen) according to the manufacturer's instructions. Manual sequencing was carried out by using the Thermo-Sequenase radiolabeled terminator cycle sequencing kit (Amersham Pharmacia Biotech) after a pretreatment of the purified cDNA samples with the enzymes from the Amersham Pharmacia Biotech PCR product presequencing reagent kit according to the manufacturer's instructions. Sequences were generated in both directions, and a consensus sequence was obtained.
The CLUSTAL W multiple sequence alignment program was downloaded from the European Bioinformatics Institute website (http://www.ebi.ac.uk/clustaw) and used to generate the phylogenetic trees. The method used was the neighbor-joining method. Since no difference in the trees drawn with correction (by the Kimura method) or without correction for multiple substitutions was observed, the trees shown are without such correction.
Nucleotide sequence accession numbers. The VP7 gene sequences of isolates CHRV/A90L and CHRV/A93M have been assigned accession numbers AY392446 and AY392447, respectively, by GenBank, and the VP4 gene sequences of isolates CHRV/A87J and CHRV/A93M have been assigned accession numbers AY395069 and AY395070, respectively. The VP7 gene sequence of isolate CHRV/A87J is identical to that of isolate ASP/87 (GenBank accession number U20990), and that of isolate CHRV/A88G is identical to that of isolate ASP/88 (GenBank accession number U20991).
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Number of cases of group C and group A rotavirus detected in the years in which group C rotavirus was detected
|
VP7 genes. The VP7 genes of isolates from 4 of the 8 years were able to be sequenced, these included CHRV/A87J (plus two others) from 1987, CHRV/A88G (plus one other) from 1988, CHRV/A90L from 1990, and CHRV/A93M from 1993. A comparison of the VP7 gene base sequences, as well as the deduced amino acid sequences between the central Australian isolates themselves, and the central Australian isolates and a number of human group C rotavirus isolates from other countries is shown in Table 2. A multiple alignment of the deduced VP7 amino acid sequences of the Australian and non-Australian isolates is also shown in Fig. 1. For the comparison, at least one isolate was selected from most of the countries in which human group C rotavirus had been identified and the VP7 gene sequence published.
|
View this table: [in a new window] |
TABLE 2. Sequence comparison of the VP7 gene of human group C rotavirusesa
|
![]() View larger version (41K): [in a new window] |
FIG. 1. Alignment of the deduced VP7 amino acid sequences of the 4 Australian and 10 non-Australian human group C rotavirus isolates listed in Table 2. The sequences are numbered from the first methionine residue at the start codon, i.e., positions 49 to 51 of the VP7 gene. Identical amino acids are represented by a dot.
|
It was notable that isolate OK450 was consistently the one with the greatest differences to the other isolates. This was further illustrated in the phylogenetic trees of the VP7 genes and the deduced VP7 amino acid sequences of the 14 group C rotavirus isolates, as shown in Fig. 2 and 3. It was particularly evident in the case of the tree generated from the amino acid sequences. It was also evident that the four Australian isolates did not necessarily group together, isolate CHRV/A93 M, for example, grouped together with the Chinese isolate 208 in both the base and amino acid sequence derived trees.
![]() View larger version (18K): [in a new window] |
FIG. 2. Phylogenetic tree of the VP7 genes of the 4 Australian (CHRV/A87J, CHRV/A88G, CHRV/A90L, CHRV/A93 M) and the 10 non-Australian (Preston, Belém, Solano, ad957, OK450, K9304, 208, KA4/949, Jajeri, and Moduganari) group C rotavirus isolates compared in Table 2.
|
![]() View larger version (17K): [in a new window] |
FIG. 3. Phylogenetic tree of the amino acid sequences deduced from the VP7 genes of the 4 Australian (CHRV/A87J, CHRV/A88G, CHRV/A90L, and CHRV/A93 M) and 10 non-Australian (Preston, Belém, Solano, ad957, OK450, K9304, 208, KA4/949, Jajeri, and Moduganari) group C rotavirus isolates compared in Table 2.
|
|
View this table: [in a new window] |
TABLE 3. Sequence comparison of the VP4 gene of human group C rotavirusesa
|
![]() View larger version (48K): [in a new window] |
FIG. 4. Alignment of the deduced VP4 amino acid sequences of the two Australian and five non-Australian human group C rotavirus isolates listed in Table 3. The sequences are numbered from the first methionine residue at the start codon, i.e., positions 21 to 23 of the VP4 gene. Identical amino acids are represented by a dot.
|
![]() View larger version (10K): [in a new window] |
FIG. 5. Phylogenetic tree of the VP4 genes of the two Australian (CHRV/A87J and CHRV/A93) and five non-Australian (Bristol, Belém, 208, Jajeri, and Moduganari) group C rotavirus isolates compared in Table 3.
|
![]() View larger version (10K): [in a new window] |
FIG. 6. Phylogenetic tree of the amino acid sequences deduced from the VP4 genes of the two Australian (CHRV/A87J and CHRV/A93 M) and five non-Australian (Bristol, Belém, 208, Jajeri, and Moduganari) group C rotavirus isolates compared in Table 3.
|
|
|
|---|
With the widespread use of commercially available detection kits, which do not detect group C rotavirus, forming the basis of many rotavirus surveys it could, however, still be that individual cases of group C rotavirus infection in Australia (and elsewhere) have not been and are not being detected. Also, group C rotavirus is often not actively looked for, even though sensitive but also time-consuming and relatively expensive methods for detection such as EIA and RT-PCR are available. In the present study the use of the relatively insensitive method of electron microscopy, together with PAGE, to detect virus very probably meant that cases of group C rotavirus infection would have been missed.
In other countries serological surveys have suggested that group C rotavirus infections are far more common than actual virus identification may have indicated (2, 7, 13, 19). These surveys, however, also included adults, among whom there was usually a higher level of group C rotavirus seropositivity than among infants and young children. Adults were not included in the survey reported on here and in central Australia adults are unlikely to visit a hospital for treatment for gastroenteritis unless it is very serious.
The present study is the first that has looked at the incidence of group C rotavirus over such a relatively long time period in the same region, making it a potentially useful one for following the evolution of the viruses. Central Australia is a very isolated region, although it is also a major national and international tourist destination. It is therefore unfortunate that the VP7 and VP4 genes of isolates spanning only 7 years were able to be sequenced.
Changes in the sequences of both the VP7 and VP4 genes were evident over the 7-year period but they were few, particularly relative to the differences in sequence between the equivalent human and animal group C rotavirus genes (1, 3, 4, 6, 9). This indicates that the evolution or drift of these genes is slow. It is also very much in keeping with the results of other studies in which the sequences of these human group C rotavirus genes from isolates from a number of different countries were compared and a very high degree of sequence conservation was found (1, 3, 4, 6, 9). Our results, including the VP7 and VP4 gene sequence comparisons between the central Australian and overseas isolates, therefore confirm and extend the findings presented in the other studies. These results also support the contention that human group C rotaviruses evolved relatively recently and possibly belong to a single globally distributed genotype (3, 6, 9).
Prior to the present study the VP4 gene sequences of only five different human group C rotavirus isolates had been published, and the present study has added the sequences of a further two, with the results continuing to show the very high degree of sequence conservation evident so far in this gene among isolates worldwide. Considering this relatively low number of isolates from which the VP4 genes have been sequenced, more human group C rotavirus isolates should be analyzed to confirm whether the level of conservation in this gene is really as high as currently appears.
It has become evident that as more human group C rotavirus isolates have been identified in different countries, a few have now been determined to have greater VP7 gene sequence differences from most of the other such isolates identified than was apparent in earlier years. Certainly with differences greater than those published in some of the earlier VP7 gene sequence comparisons. Examples of such isolates are OK450 from Japan and to a lesser extent Solano from Argentina. It is the difficulty in adapting human group C rotavirus to cell culture that has hindered the use of neutralization for testing for actual antigenic differences between isolates. However, now that such adaptation has been achieved (18), it would be of interest to try to adapt particularly the more different isolates to growth in cultured cells and then to test whether the greater differences in amino acid sequence were manifested as significant antigenic and possibly serotypic differences.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»